These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
77 related articles for article (PubMed ID: 7618632)
1. Effect of lovastatin administered every other day on serum low-density lipoprotein cholesterol > 160 mg/dl. Rindone JP; Achacoso R; Bledsoe R Am J Cardiol; 1995 Aug; 76(4):312-3. PubMed ID: 7618632 [TBL] [Abstract][Full Text] [Related]
2. The use of alternate-day lovastatin in hypercholesterolemic men. Dennis VC; Britton ML; Sirmans SM; Letassy NA; Freeman DA Ann Pharmacother; 1997 Jun; 31(6):708-12. PubMed ID: 9184709 [TBL] [Abstract][Full Text] [Related]
4. Cholesterol-lowering effects of a 10 mg daily dose of lovastatin in patients with initial total cholesterol levels 200 to 240 mg/dl (5.18 to 6.21 mmol/liter). Rubinstein A; Lurie Y; Groskop I; Weintrob M Am J Cardiol; 1991 Nov; 68(11):1123-6. PubMed ID: 1951068 [TBL] [Abstract][Full Text] [Related]
5. A multicenter comparison of lovastatin and probucol for treatment of severe primary hypercholesterolemia. The Lovastatin Study Group IV. Am J Cardiol; 1990 Sep; 66(8):22B-30B. PubMed ID: 2206033 [TBL] [Abstract][Full Text] [Related]
6. Effects of policosanol and lovastatin on lipid profile and lipid peroxidation in patients with dyslipidemia associated with type 2 diabetes mellitus. Castaño G; Menéndez R; Más R; Amor A; Fernández JL; González RL; Lezcay M; Alvarez E Int J Clin Pharmacol Res; 2002; 22(3-4):89-99. PubMed ID: 12837046 [TBL] [Abstract][Full Text] [Related]
7. Combination therapy with low-dose lovastatin and niacin is as effective as higher-dose lovastatin. Gardner SF; Schneider EF; Granberry MC; Carter IR Pharmacotherapy; 1996; 16(3):419-23. PubMed ID: 8726600 [TBL] [Abstract][Full Text] [Related]
8. Management of primary mixed hyperlipidemia with lovastatin. Vega GL; Grundy SM Arch Intern Med; 1990 Jun; 150(6):1313-9. PubMed ID: 2353864 [TBL] [Abstract][Full Text] [Related]
9. [Lovastatin in the treatment of hypercholesterolemia in non-insulin-dependent diabetes mellitus patients]. Zanella MT; Plavinik F; Zampieri M; Peres RB; Ribeiro AB Arq Bras Cardiol; 1993 Jul; 61(1):27-31. PubMed ID: 8285861 [TBL] [Abstract][Full Text] [Related]
10. Comparison of gemfibrozil and lovastatin in patients with high low-density lipoprotein and low high-density lipoprotein cholesterol levels. McKenney JM; Barnett MD; Wright JT; Proctor JP Arch Intern Med; 1992 Sep; 152(9):1781-7. PubMed ID: 1520045 [TBL] [Abstract][Full Text] [Related]
11. Effects of lovastatin on hepatic expression of the low-density lipoprotein receptor in nephrotic rats. Wei LX; Chen L; Wang WM; Zhang XH; Wu JB; Liang SF; Shu GY Genet Mol Res; 2014 Feb; 13(1):938-44. PubMed ID: 24634114 [TBL] [Abstract][Full Text] [Related]
12. [A comparison of bezafibrate and lovastatin treatment at the usual doses in post-heart transplant hyperlipemia]. Zambrana García JL; López Miranda J; Anguita Sánchez M; Blanco Cerrada J; Vallés Belsúe F; Casares Mediavilla J; Muñoz Carvajal I; Jiménez Perepérez JA; Pérez Jiménez F Rev Esp Cardiol; 1996 Dec; 49(12):892-8. PubMed ID: 9026840 [TBL] [Abstract][Full Text] [Related]
13. Comparative dose efficacy study of atorvastatin versus simvastatin, pravastatin, lovastatin, and fluvastatin in patients with hypercholesterolemia (the CURVES study). Jones P; Kafonek S; Laurora I; Hunninghake D Am J Cardiol; 1998 Mar; 81(5):582-7. PubMed ID: 9514454 [TBL] [Abstract][Full Text] [Related]
14. [Effectiveness, tolerance and safety of simvastatin in comparison with bezafibrate in treatment of hypercholesterolemia]. Lechleitner M; Sailer S; Irsigler H; Klein W; Patsch JR Wien Med Wochenschr; 1995; 145(21):577-83. PubMed ID: 8560901 [TBL] [Abstract][Full Text] [Related]
15. Efficacy of once-daily extended-release lovastatin as compared to immediate-release lovastatin in patients with hypercholesterolemia. Lukacsko P; Walters EJ; Cullen EI; Niecestro R; Friedhoff LT Curr Med Res Opin; 2004 Jan; 20(1):13-8. PubMed ID: 14741066 [TBL] [Abstract][Full Text] [Related]
16. Expanded clinical evaluation of lovastatin (EXCEL) study: design and patient characteristics of a double-blind, placebo-controlled study in patients with moderate hypercholesterolemia. Bradford RH; Shear CL; Chremos AN; Dujovne C; Franklin FA; Hesney M; Higgins J; Langendörfer A; Pool JL; Schnaper H Am J Cardiol; 1990 Sep; 66(8):44B-55B. PubMed ID: 2206036 [TBL] [Abstract][Full Text] [Related]
17. A multicenter, double-blind, one-year study comparing safety and efficacy of atorvastatin versus simvastatin in patients with hypercholesterolemia. Dart A; Jerums G; Nicholson G; d'Emden M; Hamilton-Craig I; Tallis G; Best J; West M; Sullivan D; Bracs P; Black D Am J Cardiol; 1997 Jul; 80(1):39-44. PubMed ID: 9205017 [TBL] [Abstract][Full Text] [Related]
19. Complementarity of colestipol, niacin, and lovastatin in treatment of severe familial hypercholesterolemia. Malloy MJ; Kane JP; Kunitake ST; Tun P Ann Intern Med; 1987 Nov; 107(5):616-23. PubMed ID: 3662275 [TBL] [Abstract][Full Text] [Related]